Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

47243 Press Releases
DateTitleCompany
08 Apr 10 Takeda backs British amputee football team for 2010 World Cup Takeda UK
08 Apr 10 New ‘Stem Cell Mobilisation’ Therapy Recommended by the All Wales Medicines Strategy Group Genzyme,
Published by
PharmiWeb.com
08 Apr 10 Seattle Genetics, Takeda and Millennium Announce Initiation of Phase III AETHERA Trial of Brentuximab Vedotin (SGN-35) for Post-Transplant Hodgkin Lymphoma Seattle Genetics Inc.,
Published by
Business Wire
08 Apr 10 Teva to Present New Data on Multiple Sclerosis and Parkinson's Disease at the 62nd American Academy of Neurology Annual Meeting Teva,
Published by
PharmiWeb.com
08 Apr 10 BIOTRONIK Gains European Approval for Complete Series of MRI-Conditional Pacemakers and Leads BIOTRONIK SE & Co. KG,
Published by
Business Wire
08 Apr 10 Biogen Idec to Report First Quarter 2010 Financial Results on April 20, 2010 Biogen Idec Inc.,
Published by
Business Wire
08 Apr 10 OrbiMed Expands Global Investment Team into Israel OrbiMed,
Published by
Business Wire
08 Apr 10 New England Journal of Medicine Publishes PROVE 3 Trial Showing Telaprevir-Based Regimens Significantly Increased Sustained Viral Response (SVR) Rates in Patients Who Did Not Achieve SVR with Prior HCV Therapy Vertex Pharmaceuticals Incorporated,
Published by
Business Wire
07 Apr 10 Bernstein Liebhard LLP Announces Submission Deadline for Investors of Medivation, Inc. Bernstein Liebhard LLP,
Published by
Business Wire
07 Apr 10 INTERIM RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2009 Bioventix plc,
Published by
PharmiWeb.com
07 Apr 10 Teva to Present New Data on Multiple Sclerosis and Parkinson’s Disease at the 62nd American Academy of Neurology Annual Meeting Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
07 Apr 10 Teva Announces Final Approval of Generic Hyzaar® and Cozaar® Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
07 Apr 10 Domainex lead optimisation services facilitate a new cancer drug discovery programme DOMAINEX LTD,
Published by
PharmiWeb.com
07 Apr 10 Merck to Hold First-Quarter 2010 Sales and Earnings Conference Call on May 4 Merck & Co. Inc.,
Published by
Business Wire
07 Apr 10 New Survey Reveals That Parents Lack Information about Dehydration and Its Treatment Baxter International Inc.,
Published by
Business Wire
07 Apr 10 Big Idea Challenge to Bioscience in the East Midlands Medilink East Midlands,
Published by
Integra Communications Ltd
07 Apr 10 ICON and Tigermed Sign Alliance Agreement in China ICON plc,
Published by
Business Wire
07 Apr 10 Thierry Hercend joins Covagen's Scientific Advisory Board Covagen
07 Apr 10 Novel agent for treatment of Parkinson's disease - Lu AE04621 - enters Lundbeck's development pipeline Lundbeck,
Published by
PharmiWeb.com
07 Apr 10 New FLEXYTE® Protease Assays enable information-rich output, miniaturization and multiplexing Almac,
Published by
PharmiWeb.com
07 Apr 10 Almac wins excellence in ‘Innovation’ category at the tenth annual Belfast Telegraph / BMI Northern Ireland Business Awards Almac,
Published by
PharmiWeb.com
06 Apr 10 Accumetrics, Inc. Announces Completion of GRAVITAS Trial Enrollment Accumetrics Inc.,
Published by
PR Newswire
06 Apr 10 Daiichi Sankyo Submits First New Drug Application for Oral Factor Xa Inhibitor, Edoxaban Daiichi Sankyo,
Published by
PR Newswire
06 Apr 10 Frost & Sullivan: Orphan Drugs to Create Paradigm Shift in the Pharmaceutical Industry! Frost & Sullivan,
Published by
PR Newswire
06 Apr 10 New Meaningful Use Best-Practices Library Helps Hospitals Effectively Implement Electronic Health Records to Improve the Health of Their Communities Premier Inc.,
Published by
Business Wire
06 Apr 10 Conceptus® to Hold First Quarter Financial Results Conference Call April 20, 2010 Conceptus Inc.,
Published by
Business Wire
06 Apr 10 Vertex Pharmaceuticals Announces the Date of its First Quarter 2010 Financial Results Conference Call and Webcast Vertex Pharmaceuticals Incorporated,
Published by
Business Wire
06 Apr 10 BioAlliance Pharma Announces Licensing of European Commercialization Rights for Loramyc® and Setofilm® to the Therabel Group in a €48.5 Million Deal BioAlliance Pharma SA,
Published by
Business Wire
06 Apr 10 Leading Scientist Professor Véronique Préat Highlights the Growth of and Challenges in the Pharmaceutical Development of Biotechnology Drugs at NextPharma's SPDC Inauguration Event NextPharma Technologies
05 Apr 10 United BioSource Corporation to Participate in Panel Discussion on Risk Management and Patient Safety at Partnerships in Clinical Trials United BioSource Corporation,
Published by
Business Wire
Advertising